Hypertension Clinical Trials

143 studies are recruiting for hypertension in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

  1. Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

    The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adj…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Clinical Trial Site, Birmingham, Alabama
    Locations
    1153 in total
    Run by
    Alnylam Pharmaceuticals
  2. Diabetes and Heart Disease Risk in Blacks

    It is unknown if obesity contributes to the development of heart disease in African American men and women. This study was created to determine whether there is a relationship between sex and body size and the incidence of heart disease in African American men and women. Researchers will attempt to…

    Stage
    Not phased
    Ages
    18 to 70
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  3. Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

    Background: The adrenal gland makes the hormone aldosterone. This helps regulate blood pressure. An adrenal gland tumor that makes too much aldosterone can cause high blood pressure and low potassium. The cause of these tumors is unknown, but sometimes they are inherited. Objective: To study the ge…

    Stage
    Not phased
    Ages
    7 to 70
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  4. EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

    This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglif…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Pinnacle Research Group, LLC, Anniston, Alabama
    Locations
    1143 in total
    Run by
    Boehringer Ingelheim
  5. Study of Disrupted Sleep in Somali Americans

    The aims of this study are to determine the types and severity of previously undiagnosed sleep deficiencies in otherwise healthy Somali Americans, apply a research framework to define psychosocial, behavioral, environmental, and biological mechanisms mediating sleep deficiencies in Somali Americans…

    Stage
    Not phased
    Ages
    18 to 70
    Site
    Mayo Clinic in Rochester, Rochester, Minnesota
    Run by
    Mayo Clinic
  6. OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device

    This study, with N = 85 participants minimum over 3 visits spread over 7 days, has been designed to assess the accuracy and precision of the Blood Pressure and pulse rate values as generated by Aktiia.product-G1-US for up to 7 days after initialization in a cohort of subjects representative of the …

    Stage
    Not phased
    Ages
    22 to 59
    Site
    Parameters Research Laboratory, Broomfield, Colorado
    Run by
    Aktiia SA
  7. A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

    The purpose of this study is to evaluate the efficacy, pharmacodynamics (PD), and safety of ALN-AGT01 RVR in participants with mild to moderate hypertension pretreated with zilebesiran.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Clinical Trial Site, Lake Forest, California
    Locations
    3 in total
    Run by
    Alnylam Pharmaceuticals
  8. Impact GLP-1 Agonists Following Bariatric

    Glucagon-like peptide 1 (GLP-1) is a hormone that helps regulate blood glucose levels through improved insulin sensitivity and release of insulin from the pancreas, control hunger, induce satiety and plays a role in the metabolic health of a person. GLP-1 receptor agonists (GLP1-RAs) have been show…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Missouri Hospital, Columbia, Missouri
    Run by
    University of Missouri-Columbia
  9. Implementation of a Beauty Salon-Based Strategy for Blood Pressure Management Among Women

    CROWN is a two-arm, cluster-randomized pilot trial testing the feasibility and preliminary efficacy of a salon-based cardiovascular intervention - training stylists as Heart Health Stylists to conduct in-salon blood pressure screenings, home monitoring with telehealth support, community health-work…

    Stage
    Not phased
    Ages
    18 to 79
    Site
    Johns Hopkins University, Baltimore, Maryland
    Run by
    Johns Hopkins University
  10. Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

    The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic ner…

    Stage
    EARLY_Phase 1
    Ages
    18 to 55
    Site
    University of Texas Southwestern Medical Center, Dallas, Texas
    Run by
    University of Texas Southwestern Medical Center
  11. Childhood-Onset Essential Hypertension Natural History Study

    Background: Childhood-onset essential hypertension (COEH) is high blood pressure that develops in children and teens. High blood pressure is a major risk factor for heart disease. COEH is more likely to be caused by changes in genes rather than by factors like stress or diet. Researchers want to le…

    Stage
    Not phased
    Ages
    2 to 99
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Human Genome Research Institute (NHGRI)
  12. THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

    The primary objective of the THRIVE Pivotal study is to demonstrate the adjunctive effectiveness and the safety of the TIVUS system in: 1. subjects with uncontrolled hypertension (HTN) receiving 0 - 2 anti-hypertensive drugs of different classes in whom the anti-hypertensive medications will be sto…

    Stage
    Not phased
    Ages
    22 to 75
    Site
    Cardiology, PC, Birmingham, Alabama
    Locations
    50 in total
    Run by
    SoniVie Inc.
  13. Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

    The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Western Nephrology and Metabolic Bone Disease, PC - Arvada, Arvada, Colorado
    Locations
    11 in total
    Run by
    Kardigan, Inc.
  14. Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH

    The goal of the Arizona Community Engagement Alliance (AZ-CEAL) will be to combine social care with healthcare programs. The study will be connecting selected patients from clinics with trained community health workers (CHW) who will assist participants in getting the help that is needed for their …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Banner University Medical Center South, Tucson, Arizona
    Locations
    2 in total
    Run by
    Sairam Parthasarathy
  15. MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors

    Inflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research will study the effects…

    Stage
    Not phased
    Ages
    40 to 60
    Site
    Clinical Nutrition Research Center, Chicago, Illinois
    Run by
    Clinical Nutrition Research Center, Illinois Institute of Technology
  16. Sleep Promotion and Pediatric Hypertension

    Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.

    Stage
    Not phased
    Ages
    13 to 18
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Run by
    Children's Hospital of Philadelphia
  17. BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

    A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.

    Stage
    Not phased
    Ages
    18 and older
    Site
    HonorHealth, Scottsdale, Arizona
    Locations
    131 in total
    Run by
    Orchestra BioMed, Inc
  18. Preventative Screening and Health Coaching in a Food Insecure Population

    The goal of this longitudinal study is to investigate the role of virtual health coaching on mitigation of cardiometabolic disease risk in an underserved, food insecure population. The main questions it aims to answer are: * Does longitudinal, individualized health coaching directed at lifestyle mo…

    Stage
    Not phased
    Ages
    40 to 75
    Site
    Rush University Medical Center, Chicago, Illinois
    Run by
    Rush University Medical Center
  19. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK…

    Stage
    Not phased
    Ages
    0 to 20
    Site
    Lucile Packard Children's Hospital, Palo Alto, California
    Locations
    52 in total
    Run by
    Duke University
  20. REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension

    The goal of the REFOCUS-HTN US-WEST program is to gain a better understanding of the role of a hormone called aldosterone in the development of hypertension. The SCALED sub-study is an observational cohort study that will enroll from REFOCUS-HTN cohort for prospective data collection.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Kaiser Permanente Northern California, Oakland, California
    Run by
    Kaiser Permanente
  21. Secondhand Tobacco Smoke and Cardiovascular Disease

    This is a double-blind randomized placebo-controlled crossover clinical trial of efficacy and safety of an FDA-approved angiotensin receptor blocker (losartan) to improve cardiopulmonary outcomes in individuals with pre-Chronic Obstructive Pulmonary Disease (COPD) due to prolonged exposure to secon…

    Stage
    Phase 4
    Ages
    40 and older
    Site
    San Francisco Veterans' Affairs Medical Center, San Francisco, California
    Run by
    University of California, San Francisco
  22. Ketone Ester and Salt (KEAS) in Young Adults

    Most Americans consume excess dietary salt based on the recommendations set by the American Heart Association and Dietary Guidelines for Americans. High dietary salt impairs the ability of systemic blood vessels and the kidneys to control blood pressure, which contributes to excess salt consumption…

    Stage
    Not phased
    Ages
    19 to 39
    Site
    Indiana University, School of Public Health, Bloomington, Indiana
    Run by
    Indiana University
  23. Ketone Ester And Salt (KEAS) in Older Adults

    Most Americans consume excess dietary salt based on the recommendations set by the American Heart Association and Dietary Guidelines for Americans. High dietary salt impairs blood pressure control by affecting systemic blood vessels and the kidneys. These changes contribute to excess salt consumpti…

    Stage
    Not phased
    Ages
    50 to 85
    Site
    School of Public Health, Bloomington, Indiana
    Run by
    Indiana University
  24. Groceries for Residents of Southeastern USA to Stop Hypertension

    GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Run by
    Beth Israel Deaconess Medical Center
  25. A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

    The goal of this clinical study is to evaluate the safety and efficacy of percutaneous pulmonary artery denervation with the Multi-Pole Pulmonary Artery Radiofrequency Ablation Enhancor System in patients with combined pre- and post-capillary pulmonary hypertension (CpcPH) associated with left hear…

    Stage
    Not phased
    Ages
    18 to 85
    Site
    Banner - University Medical Center Tucson, Tucson, Arizona
    Locations
    6 in total
    Run by
    Pulnovo Medical, Inc.

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.